Letter: Reassessing Tenofovir Alafenamide Use Throughout Pregnancy-A New Horizon in Hepatitis B Therapy. Authors' Reply.
Saved in:
| Title: | Letter: Reassessing Tenofovir Alafenamide Use Throughout Pregnancy-A New Horizon in Hepatitis B Therapy. Authors' Reply. |
|---|---|
| Authors: | Pan X; Department of Infectious Diseases, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Pan CQ; Guangzhou Medical University, Guangzhou, China.; Division of Gastroenterology and Hepatology, Department of Medicine, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, USA. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2025 Aug; Vol. 62 (3), pp. 366-367. Date of Electronic Publication: 2025 Jun 03. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.70221 |
